Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Vertex picks up global rights to two HCV candidates from Alios; Vertex ends HCV program

Executive Summary

Alios BioPharma Inc. (antivirals) has licensed Vertex Pharmaceuticals Inc. (treatments for hepatitis C, cystic fibrosis, epilepsy, and other conditions) exclusive worldwide rights to the preclinical hepatitis C nucleotide analogues ALS2200 and ALS2158.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Intra-Biotech Deal

Related Companies

UsernamePublicRestriction

Register